Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety and Efficacy of YB-1113 in Treatment of POI

This phase 1 study is to evaluate the safety and tolerability of YB-1113 administered via intravenous (IV) infusion in the treatment of premature ovarian insufficiency (POI).

Participants needed: 6
Trial details
Phase: Phase 1Age: 18-39Biological sex: FemaleType: InterventionalSponsor: Bright Cell, Inc.Updated: Dec 23, 2025
Eligibility criteria

Female, 18 to <40 years old, who are seeking fertility or preservation of fertil... [+5]

1. Primary amenorrhea or FSH ≥ 40 IU/L [+16]

Status: Not yet recruiting

BC-101 in Treatment of Nasolabial Fold Wrinkles

This is an open-label, single-arm, dose-escalating study to evaluate the safety and tolerability of BC-101 administered via subcutaneous/intradermal injection in the treatment of moderate to severe nasolabial folds.

Participants needed: 9
Trial details
Phase: Phase 1Age: 40-80Biological sex: AllType: InterventionalSponsor: Bright Cell, Inc.Updated: Dec 29, 2025
Eligibility criteria

Subjects who are in general good health condition. [+4]

Subjects who have an active cutaneous infection on the face. [+6]